# CBD Cannabis Extract: Pharmacokinetic Studies

> **NCT04280289** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Mississippi, Oxford** · enrollment: 10 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** cannabidiol extract

## Key facts

- **NCT ID:** NCT04280289
- **Lead sponsor:** University of Mississippi, Oxford
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04280289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04280289, "CBD Cannabis Extract: Pharmacokinetic Studies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04280289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*